Literature DB >> 15026707

[Bioterrorism with brucellosis].

Amélie Guihot1, Philippe Bossi, François Bricaire.   

Abstract

A CONTAMINATING SPRAY: Brucellosis is a zoonosis due to a bacteria of the Brucella. B. melitensis species and is the principle agent of human brucellosis. The interest of Brucella as a biological weapon resides in the fact that transmission through a spray is possible, as has been reported with human contamination during abortion of infected animals or bacterial spraying in laboratories. The bacteria is highly contagious. It is suggested that 10 to 100 bacteria would be sufficient to produce a contaminating spray for humans. THE MENACE: In 1954, B. suis was the first infectious agent used as a biological weapon in the United States. Several other countries have been suspected of studying the agent as a biological weapon, but to date, no use of Brucella in a bioterrorist attack has been reported. THE EXTENT OF RISK: Brucella, and notably B. melitensis and B. suis, are considered as agents unlikely to be used as biological weapons: their incubation is long, the majority of infections are asymptomatic and mortality is low. However, the morbidity of this agent should not be underrated since it leads to chronic and disabling pathologies.

Entities:  

Mesh:

Year:  2004        PMID: 15026707     DOI: 10.1016/s0755-4982(04)98500-4

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  5 in total

1.  Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16 M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-/- mouse model.

Authors:  A M Arenas-Gamboa; A C Rice-Ficht; Y Fan; M M Kahl-McDonagh; T A Ficht
Journal:  Clin Vaccine Immunol       Date:  2011-12-14

2.  Raman spectroscopy as a potential tool for detection of Brucella spp. in milk.

Authors:  Susann Meisel; Stephan Stöckel; Mandy Elschner; Falk Melzer; Petra Rösch; Jürgen Popp
Journal:  Appl Environ Microbiol       Date:  2012-06-01       Impact factor: 4.792

3.  Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice.

Authors:  A M Arenas-Gamboa; A C Rice-Ficht; M M Kahl-McDonagh; T A Ficht
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

4.  Brucella spp noncanonical LPS: structure, biosynthesis, and interaction with host immune system.

Authors:  Patrícia Gomes Cardoso; Gilson Costa Macedo; Vasco Azevedo; Sergio Costa Oliveira
Journal:  Microb Cell Fact       Date:  2006-03-23       Impact factor: 5.328

Review 5.  Development and trial of vaccines against Brucella.

Authors:  Jonathan Lalsiamthara; John Hwa Lee
Journal:  J Vet Sci       Date:  2017-08-31       Impact factor: 1.672

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.